Search Results - "Slifka, Dawn K"

Development of a next-generation chikungunya virus vaccine based on the HydroVax platform by Slifka, Dawn K, Raué, Hans-Peter, Weber, Whitney C, Andoh, Takeshi F, Kreklywich, Craig N, DeFilippis, Victor R, Streblow, Daniel N, Slifka, Mark K, Amanna, Ian J

“…Chikungunya virus (CHIKV) is an emerging/re-emerging mosquito-borne pathogen responsible for explosive epidemics of febrile illness characterized by…”
Get full text

Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine by Poore, Elizabeth A, Slifka, Dawn K, Raué, Hans-Peter, Thomas, Archana, Hammarlund, Erika, Quintel, Benjamin K, Torrey, Lindsay L, Slifka, Ariel M, Richner, Justin M, Dubois, Melissa E, Johnson, Lawrence P, Diamond, Michael S, Slifka, Mark K, Amanna, Ian J

“…Abstract West Nile virus (WNV) is a mosquito-transmitted pathogen with a wide geographical range that can lead to long-term disability and death in some cases…”
Get full text

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults by Woods, Christopher W., Sanchez, Ana M., Swamy, Geeta K., McClain, Micah T., Harrington, Lynn, Freeman, Debra, Poore, Elizabeth A., Slifka, Dawn K., Poer DeRaad, Danae E., Amanna, Ian J., Slifka, Mark K., Cai, Shu, Shahamatdar, Venus, Wierzbicki, Michael R., Amegashie, Cyrille, Walter, Emmanuel B.

“…West Nile virus (WNV) is the most common mosquito-borne infection in the United States. HydroVax-001 WNV is a hydrogen peroxide inactivated, whole virion…”
Get full text